ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Immunodeficiency Virus Type-1 Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-36S17850
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Immunodeficiency Virus Type 1 Market Research Report 2024
BUY CHAPTERS

Global Human Immunodeficiency Virus Type-1 Market Research Report 2024

Code: QYRE-Auto-36S17850
Report
August 2024
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
Sanofi
Sanofi S A
Pfizer Inc
GSK
Roche
Bristol–Myers Squibb
Merck& Co. Inc
Viatris
Astrazeneca plc
Novartis
Bayer

Human Immunodeficiency Virus Type-1 Market

The global Human Immunodeficiency Virus Type-1 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Human Immunodeficiency Virus Type-1 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Immunodeficiency Virus Type-1 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Immunodeficiency Virus Type-1 in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Immunodeficiency Virus Type-1 include Roche, Bristol Myers Squibb, Merck & Co. Inc., GSK, Pfizer, Viatris, Sanofi, AstraZeneca, Novartis, Bayer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Immunodeficiency Virus Type-1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Immunodeficiency Virus Type-1.
The Human Immunodeficiency Virus Type-1 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Immunodeficiency Virus Type-1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Immunodeficiency Virus Type-1 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Human Immunodeficiency Virus Type-1 Market Report

Report Metric Details
Report Name Human Immunodeficiency Virus Type-1 Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Bristol Myers Squibb, Merck & Co. Inc., GSK, Pfizer, Viatris, Sanofi, AstraZeneca, Novartis, Bayer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Human Immunodeficiency Virus Type-1 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Human Immunodeficiency Virus Type-1 Market report?

Ans: The main players in the Human Immunodeficiency Virus Type-1 Market are Roche, Bristol Myers Squibb, Merck & Co. Inc., GSK, Pfizer, Viatris, Sanofi, AstraZeneca, Novartis, Bayer

What are the Application segmentation covered in the Human Immunodeficiency Virus Type-1 Market report?

Ans: The Applications covered in the Human Immunodeficiency Virus Type-1 Market report are Hospital Pharmacies, Retail Pharmacies

What are the Type segmentation covered in the Human Immunodeficiency Virus Type-1 Market report?

Ans: The Types covered in the Human Immunodeficiency Virus Type-1 Market report are Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs), Protease Inhibitors (PIs), Integrase Inhibitor, Others

Recommended Reports

HIV/AIDS Therapy

Virus Diagnostics

Infectious Disease Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.2.3 Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
1.2.4 Protease Inhibitors (PIs)
1.2.5 Integrase Inhibitor
1.2.6 Others
1.3 Market by Application
1.3.1 Global Human Immunodeficiency Virus Type-1 Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Immunodeficiency Virus Type-1 Market Perspective (2019-2030)
2.2 Global Human Immunodeficiency Virus Type-1 Growth Trends by Region
2.2.1 Global Human Immunodeficiency Virus Type-1 Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Immunodeficiency Virus Type-1 Historic Market Size by Region (2019-2024)
2.2.3 Human Immunodeficiency Virus Type-1 Forecasted Market Size by Region (2025-2030)
2.3 Human Immunodeficiency Virus Type-1 Market Dynamics
2.3.1 Human Immunodeficiency Virus Type-1 Industry Trends
2.3.2 Human Immunodeficiency Virus Type-1 Market Drivers
2.3.3 Human Immunodeficiency Virus Type-1 Market Challenges
2.3.4 Human Immunodeficiency Virus Type-1 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Immunodeficiency Virus Type-1 Players by Revenue
3.1.1 Global Top Human Immunodeficiency Virus Type-1 Players by Revenue (2019-2024)
3.1.2 Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Players (2019-2024)
3.2 Global Human Immunodeficiency Virus Type-1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Immunodeficiency Virus Type-1 Revenue
3.4 Global Human Immunodeficiency Virus Type-1 Market Concentration Ratio
3.4.1 Global Human Immunodeficiency Virus Type-1 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus Type-1 Revenue in 2023
3.5 Global Key Players of Human Immunodeficiency Virus Type-1 Head office and Area Served
3.6 Global Key Players of Human Immunodeficiency Virus Type-1, Product and Application
3.7 Global Key Players of Human Immunodeficiency Virus Type-1, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Immunodeficiency Virus Type-1 Breakdown Data by Type
4.1 Global Human Immunodeficiency Virus Type-1 Historic Market Size by Type (2019-2024)
4.2 Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Type (2025-2030)
5 Human Immunodeficiency Virus Type-1 Breakdown Data by Application
5.1 Global Human Immunodeficiency Virus Type-1 Historic Market Size by Application (2019-2024)
5.2 Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Immunodeficiency Virus Type-1 Market Size (2019-2030)
6.2 North America Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Immunodeficiency Virus Type-1 Market Size by Country (2019-2024)
6.4 North America Human Immunodeficiency Virus Type-1 Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Immunodeficiency Virus Type-1 Market Size (2019-2030)
7.2 Europe Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2019-2024)
7.4 Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size (2019-2030)
8.2 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Immunodeficiency Virus Type-1 Market Size (2019-2030)
9.2 Latin America Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (2019-2024)
9.4 Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size (2019-2030)
10.2 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Human Immunodeficiency Virus Type-1 Introduction
11.1.4 Roche Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Details
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Introduction
11.2.4 Bristol Myers Squibb Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Merck & Co. Inc.
11.3.1 Merck & Co. Inc. Company Details
11.3.2 Merck & Co. Inc. Business Overview
11.3.3 Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Introduction
11.3.4 Merck & Co. Inc. Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024)
11.3.5 Merck & Co. Inc. Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Human Immunodeficiency Virus Type-1 Introduction
11.4.4 GSK Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024)
11.4.5 GSK Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Human Immunodeficiency Virus Type-1 Introduction
11.5.4 Pfizer Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Viatris
11.6.1 Viatris Company Details
11.6.2 Viatris Business Overview
11.6.3 Viatris Human Immunodeficiency Virus Type-1 Introduction
11.6.4 Viatris Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024)
11.6.5 Viatris Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Human Immunodeficiency Virus Type-1 Introduction
11.7.4 Sanofi Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Human Immunodeficiency Virus Type-1 Introduction
11.8.4 AstraZeneca Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024)
11.8.5 AstraZeneca Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Human Immunodeficiency Virus Type-1 Introduction
11.9.4 Novartis Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Human Immunodeficiency Virus Type-1 Introduction
11.10.4 Bayer Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024)
11.10.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Companies
Sanofi
Sanofi S A
Pfizer Inc
GSK
Roche
Bristol–Myers Squibb
Merck& Co. Inc
Viatris
Astrazeneca plc
Novartis
Bayer
List of Tables
 Table 1. Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
 Table 3. Key Players of Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
 Table 4. Key Players of Protease Inhibitors (PIs)
 Table 5. Key Players of Integrase Inhibitor
 Table 6. Key Players of Others
 Table 7. Global Human Immunodeficiency Virus Type-1 Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Human Immunodeficiency Virus Type-1 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 9. Global Human Immunodeficiency Virus Type-1 Market Size by Region (2019-2024) & (US$ Million)
 Table 10. Global Human Immunodeficiency Virus Type-1 Market Share by Region (2019-2024)
 Table 11. Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 12. Global Human Immunodeficiency Virus Type-1 Market Share by Region (2025-2030)
 Table 13. Human Immunodeficiency Virus Type-1 Market Trends
 Table 14. Human Immunodeficiency Virus Type-1 Market Drivers
 Table 15. Human Immunodeficiency Virus Type-1 Market Challenges
 Table 16. Human Immunodeficiency Virus Type-1 Market Restraints
 Table 17. Global Human Immunodeficiency Virus Type-1 Revenue by Players (2019-2024) & (US$ Million)
 Table 18. Global Human Immunodeficiency Virus Type-1 Market Share by Players (2019-2024)
 Table 19. Global Top Human Immunodeficiency Virus Type-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus Type-1 as of 2023)
 Table 20. Ranking of Global Top Human Immunodeficiency Virus Type-1 Companies by Revenue (US$ Million) in 2023
 Table 21. Global 5 Largest Players Market Share by Human Immunodeficiency Virus Type-1 Revenue (CR5 and HHI) & (2019-2024)
 Table 22. Global Key Players of Human Immunodeficiency Virus Type-1, Headquarters and Area Served
 Table 23. Global Key Players of Human Immunodeficiency Virus Type-1, Product and Application
 Table 24. Global Key Players of Human Immunodeficiency Virus Type-1, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Human Immunodeficiency Virus Type-1 Market Size by Type (2019-2024) & (US$ Million)
 Table 27. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Type (2019-2024)
 Table 28. Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 29. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Type (2025-2030)
 Table 30. Global Human Immunodeficiency Virus Type-1 Market Size by Application (2019-2024) & (US$ Million)
 Table 31. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Application (2019-2024)
 Table 32. Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 33. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Application (2025-2030)
 Table 34. North America Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. North America Human Immunodeficiency Virus Type-1 Market Size by Country (2019-2024) & (US$ Million)
 Table 36. North America Human Immunodeficiency Virus Type-1 Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Europe Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2019-2024) & (US$ Million)
 Table 39. Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2025-2030) & (US$ Million)
 Table 40. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (2019-2024) & (US$ Million)
 Table 42. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (2025-2030) & (US$ Million)
 Table 43. Latin America Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (2025-2030) & (US$ Million)
 Table 46. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 47. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2019-2024) & (US$ Million)
 Table 48. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2025-2030) & (US$ Million)
 Table 49. Roche Company Details
 Table 50. Roche Business Overview
 Table 51. Roche Human Immunodeficiency Virus Type-1 Product
 Table 52. Roche Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024) & (US$ Million)
 Table 53. Roche Recent Development
 Table 54. Bristol Myers Squibb Company Details
 Table 55. Bristol Myers Squibb Business Overview
 Table 56. Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Product
 Table 57. Bristol Myers Squibb Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024) & (US$ Million)
 Table 58. Bristol Myers Squibb Recent Development
 Table 59. Merck & Co. Inc. Company Details
 Table 60. Merck & Co. Inc. Business Overview
 Table 61. Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Product
 Table 62. Merck & Co. Inc. Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024) & (US$ Million)
 Table 63. Merck & Co. Inc. Recent Development
 Table 64. GSK Company Details
 Table 65. GSK Business Overview
 Table 66. GSK Human Immunodeficiency Virus Type-1 Product
 Table 67. GSK Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024) & (US$ Million)
 Table 68. GSK Recent Development
 Table 69. Pfizer Company Details
 Table 70. Pfizer Business Overview
 Table 71. Pfizer Human Immunodeficiency Virus Type-1 Product
 Table 72. Pfizer Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024) & (US$ Million)
 Table 73. Pfizer Recent Development
 Table 74. Viatris Company Details
 Table 75. Viatris Business Overview
 Table 76. Viatris Human Immunodeficiency Virus Type-1 Product
 Table 77. Viatris Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024) & (US$ Million)
 Table 78. Viatris Recent Development
 Table 79. Sanofi Company Details
 Table 80. Sanofi Business Overview
 Table 81. Sanofi Human Immunodeficiency Virus Type-1 Product
 Table 82. Sanofi Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024) & (US$ Million)
 Table 83. Sanofi Recent Development
 Table 84. AstraZeneca Company Details
 Table 85. AstraZeneca Business Overview
 Table 86. AstraZeneca Human Immunodeficiency Virus Type-1 Product
 Table 87. AstraZeneca Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024) & (US$ Million)
 Table 88. AstraZeneca Recent Development
 Table 89. Novartis Company Details
 Table 90. Novartis Business Overview
 Table 91. Novartis Human Immunodeficiency Virus Type-1 Product
 Table 92. Novartis Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024) & (US$ Million)
 Table 93. Novartis Recent Development
 Table 94. Bayer Company Details
 Table 95. Bayer Business Overview
 Table 96. Bayer Human Immunodeficiency Virus Type-1 Product
 Table 97. Bayer Revenue in Human Immunodeficiency Virus Type-1 Business (2019-2024) & (US$ Million)
 Table 98. Bayer Recent Development
 Table 99. Research Programs/Design for This Report
 Table 100. Key Data Information from Secondary Sources
 Table 101. Key Data Information from Primary Sources
 Table 102. Authors List of This Report


List of Figures
 Figure 1. Human Immunodeficiency Virus Type-1 Picture
 Figure 2. Global Human Immunodeficiency Virus Type-1 Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Human Immunodeficiency Virus Type-1 Market Share by Type: 2023 VS 2030
 Figure 4. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features
 Figure 5. Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs) Features
 Figure 6. Protease Inhibitors (PIs) Features
 Figure 7. Integrase Inhibitor Features
 Figure 8. Others Features
 Figure 9. Global Human Immunodeficiency Virus Type-1 Market Size by Application (2024-2030) & (US$ Million)
 Figure 10. Global Human Immunodeficiency Virus Type-1 Market Share by Application: 2023 VS 2030
 Figure 11. Hospital Pharmacies Case Studies
 Figure 12. Retail Pharmacies Case Studies
 Figure 13. Human Immunodeficiency Virus Type-1 Report Years Considered
 Figure 14. Global Human Immunodeficiency Virus Type-1 Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Human Immunodeficiency Virus Type-1 Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Human Immunodeficiency Virus Type-1 Market Share by Region: 2023 VS 2030
 Figure 17. Global Human Immunodeficiency Virus Type-1 Market Share by Players in 2023
 Figure 18. Global Top Human Immunodeficiency Virus Type-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus Type-1 as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus Type-1 Revenue in 2023
 Figure 20. North America Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Human Immunodeficiency Virus Type-1 Market Share by Country (2019-2030)
 Figure 22. United States Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Human Immunodeficiency Virus Type-1 Market Share by Country (2019-2030)
 Figure 26. Germany Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Share by Region (2019-2030)
 Figure 34. China Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Human Immunodeficiency Virus Type-1 Market Share by Country (2019-2030)
 Figure 42. Mexico Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share by Country (2019-2030)
 Figure 46. Turkey Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Human Immunodeficiency Virus Type-1 Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Roche Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2019-2024)
 Figure 50. Bristol Myers Squibb Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2019-2024)
 Figure 51. Merck & Co. Inc. Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2019-2024)
 Figure 52. GSK Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2019-2024)
 Figure 53. Pfizer Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2019-2024)
 Figure 54. Viatris Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2019-2024)
 Figure 55. Sanofi Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2019-2024)
 Figure 56. AstraZeneca Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2019-2024)
 Figure 57. Novartis Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2019-2024)
 Figure 58. Bayer Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2019-2024)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global HIV 1 Screening Tests Market Research Report 2025
Global HIV Vaccine Market Research Report 2025
Global HIV Clinical Trials Market Research Report 2025
Global HIV and AIDS Vaccine Market Research Report 2024
Global HIV and AIDS Clinical Trials Market Research Report 2025
Global Long acting Anti HIV Drug Market Research Report 2024
Global HIV Prevention Drug Market Research Report 2024
Global Human Immunodeficiency Virus Rapid Test Kit Market Research Report 2024
Human Immunodeficiency Virus HIV Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Highly Active Antiretroviral Therapy HAART Market Research Report 2024
Pediatric HIV Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Immunodeficiency Virus HIV Rapid Test Kits Market Insights Forecast to 2030
Global Artificial Intelligence AI in HIV and AIDS Market Research Report 2024
Global Anti AIDs Drug Market Insights Forecast to 2030
Global Interleukin 1 Alpha Market Research Report 2024
Global Human Immunodeficiency Virus Testing Market Research Report 2024
Global Human Immunoglobulin Market Research Report 2024
Global Patient Hygiene Aids Market Research Report 2024
HIV Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prophylactic HIV Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions